GlassScriptPhysician profile
Caroline A Sudhoff
NPI 1184133712
$3,758.16
in general payments reported to CMS, 2019-2025
29 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $602 · 2022: $1,040 · 2023: $1,368 · 2024: $458 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095 · Gift: $20.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,095.28 |
| Gift | $20.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $846.52 | 2021-2025 | Puraply, Puraply Antimicrobial, Simplimax |
| Takeda Pharmaceuticals U.S.A., INC. | $730.53 | 2021-2025 | Gattex |
| Kowa Pharmaceuticals America, INC. | $280.84 | 2022-2023 | Seglentis |
| Idorsia Pharmaceuticals US INC | $179.19 | 2023 | Quviviq |
| Abbvie INC. | $134.23 | 2023-2024 | |
| Genentech USA, INC. | $124.82 | 2021 | |
| Glaxosmithkline, LLC. | $121.32 | 2024 | Arexvy |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $119.17 | 2023 | |
| Merck Sharp & Dohme LLC | $108.40 | 2021-2022 | |
| Arthrex, INC. | $102.26 | 2024 | Arthrex |
| Sanofi-Aventis U.S. LLC | $99.44 | 2022 | |
| Braintree Laboratories, INC. | $92.42 | 2021-2024 | Sutab, Suflave |
| Heron Therapeutics, INC. | $91.42 | 2021-2022 | |
| Ethicon US, LLC | $91.25 | 2022-2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Medtronic, INC. | $86.45 | 2021-2024 | Progrip |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $80.04 | 2021-2025 | Axonics |
| Reprise Biomedical, INC. | $74.19 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $63.86 | 2024-2025 | |
| Esperion Therapeutics, INC. | $50.50 | 2021 | |
| Ferring Pharmaceuticals INC. | $48.87 | 2022-2023 | Rebyota |
| Intuitive Surgical, INC. | $48.32 | 2022 | |
| Novo Nordisk INC | $41.66 | 2022-2024 | Wegovy |
| Smith+Nephew, INC. | $26.61 | 2023 | Renasys Go V2 Home |
| La Jolla Pharmaceutical Company | $25.03 | 2021-2022 | |
| Sanara Medtech INC. | $24.80 | 2022 | |
| Trevena, INC. | $22.16 | 2022 | |
| Alpha Orthopedic Systems | $18.99 | 2022 | |
| Teleflex LLC | $13.54 | 2024 | Titan Sgs |
| Abiomed | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Sudhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.